Media coverage
27
Media coverage
Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Miami Herald Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986726952&p=1gw&v=1&x=-4R9dKW3rL_uThat7MCvyQ Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Arca Max Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986618787&p=1gw&v=1&x=7AK__rFHB2W9kmRGiAombg Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Ledger-Enquirer Country/Territory Georgia Date 10/9/24 URL ct.moreover.com/?a=54986700881&p=1gw&v=1&x=QMR1fMH4QqYmCsAtFW5D-g Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Centre Daily Times Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986701652&p=1gw&v=1&x=vMZUzdfcy7NeIgBjDP1Wyg Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Macon Telegraph Country/Territory Georgia Date 10/9/24 URL ct.moreover.com/?a=54986702549&p=1gw&v=1&x=DSQ6zc99ZDInR2aW90BtXw Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Bradenton Herald Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986703049&p=1gw&v=1&x=o32zFU4Uwow7iE_tK1E0ww Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet San Luis Obispo.com Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986704255&p=1gw&v=1&x=SO7Hemi9ltWhg8eq1gA-PQ Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Belleville News Democrat Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986707467&p=1gw&v=1&x=m5xgjPvLxyaHVaDneLO6hg Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Wichita Eagle Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986711406&p=1gw&v=1&x=8RN8UklFafvo4rdP0QhuyA Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet The Olympian Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986711465&p=1gw&v=1&x=l1-Dn1BD81Dqxi3V9quW5g Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Modesto Bee Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986711555&p=1gw&v=1&x=3Nbv5Rirtwk29NDAQaWk8Q Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Merced Sun-Star Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986712625&p=1gw&v=1&x=_HGIsxu0B_f4ii09WBnhjw Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Bellingham Herald Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986713098&p=1gw&v=1&x=U8UEj7gytFoJ73KtNqefAg Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Kentucky.com Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986713597&p=1gw&v=1&x=O1xqCyNUD29ygSE2xtjBJw Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Star-Telegram Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986714295&p=1gw&v=1&x=6O71rreEJiONrCmQfZvnZw Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Sun Herald Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986714833&p=1gw&v=1&x=vmR0VslytJQyP7_XdfNzrg Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Durham Herald-Sun Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986717007&p=1gw&v=1&x=h8w1KtRjQc1oQdp-s9o6kg Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Charlotte Observer Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986719007&p=1gw&v=1&x=5ZEciNgxAGpGjkqlUshDWQ Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Tri-City Herald Online Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986720175&p=1gw&v=1&x=gzPBAjoV8Qpph9FjIR0VEQ Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Tacoma News Tribune Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986720898&p=1gw&v=1&x=ArO_d3qHpuv9fyZstyW3IQ Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Rock Hill Herald Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986722288&p=1gw&v=1&x=uL10AWSDn2RSKXiixe-AVw Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Raleigh News & Observer Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986722640&p=1gw&v=1&x=qXnv7tURFBmnpfqVlCnaHQ Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Island Packet Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986725618&p=1gw&v=1&x=3FeWEnj4V8EsyhU_U-KKOw Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet KansasCity.com Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986737219&p=1gw&v=1&x=kJyn5hc-n71YFBEL_u0ccA Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Idaho Statesman Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986740882&p=1gw&v=1&x=-SVNwl8sJXs1Sc-LHPPe4Q Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Myrtle Beach Sun News Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986749759&p=1gw&v=1&x=JQp9-ktpt62OW_5z4N7Ntw Persons Margaret von Mehren Title A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients Media name/outlet Walla Walla Union-Bulletin Country/Territory United States Date 10/9/24 URL ct.moreover.com/?a=54986916386&p=1gw&v=1&x=3zbvCPB3lkememMFkLge3Q Persons Margaret von Mehren